Kanecia Obie Zimmerman
Clinical trials sponsored by Kanecia Obie Zimmerman, explained in plain language.
-
Major trial tests multiple drugs to tackle lingering COVID symptoms
Disease control CompletedThis study tested several different treatments to see if they could help people with Long COVID. It involved 963 adults who had persistent symptoms for at least 12 weeks after a COVID-19 infection. The trial was designed to be flexible, testing whether drugs that target leftover …
Phase: PHASE2 • Sponsor: Kanecia Obie Zimmerman • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Could a COVID pill cure long Haulers' brain fog and fatigue?
Disease control CompletedThis study tested whether the antiviral medication Paxlovid could help people suffering from Long COVID. Researchers gave 964 participants either Paxlovid or a placebo pill to see if it improved their brain fog, exercise fatigue, and dizziness. The goal was to see if reducing lin…
Phase: PHASE2 • Sponsor: Kanecia Obie Zimmerman • Aim: Disease control
Last updated Mar 05, 2026 13:59 UTC
-
New hope for long COVID's invisible symptoms: trial tests multiple therapies
Symptom relief CompletedThis study tested different treatments to help people with Long COVID who experience problems with their automatic body functions, like dizziness and a racing heart when standing up. It involved 381 adults who had these symptoms for at least 12 weeks after a COVID-19 infection. T…
Phase: PHASE2 • Sponsor: Kanecia Obie Zimmerman • Aim: Symptom relief
Last updated Mar 27, 2026 12:41 UTC
-
Heart drug trial offers hope for debilitating long COVID symptoms
Symptom relief CompletedThis study tested whether a drug called ivabradine could help people with Long COVID who experience dizziness, fatigue, and a racing heart when standing up. In this Phase 2 trial, 181 participants were randomly given either the drug or a placebo to see which was better at reducin…
Phase: PHASE2 • Sponsor: Kanecia Obie Zimmerman • Aim: Symptom relief
Last updated Mar 25, 2026 14:08 UTC